KinoTeck Therapeutics Co., Ltd
1 clinical trials · Sponsor
◉ Watch KinoTeck Therapeutics Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations (NCT06800196) | KinoTeck Therapeutics Co., Ltd | 2025-04-10 |
Track KinoTeck Therapeutics Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.